Age, years
|
72.7 ± 8.8
|
Gender, female %
|
56%
|
Educational level, years; median (IQR)
|
12.0 (6.0–15.0)
|
MMSE, median (IQR)
|
27.0 (25.0–28.0)
|
MCI type, %
|
Amnestic MCI
|
83%
|
Non-amnestic MCI
|
17%
|
APOE4 (carrying one or more ε4 allele)
|
26%
|
Reported vascular risk factors (no history/under Tx/no Tx)a, %
|
Hypertension, %
|
43/52/4%
|
Type 2 diabetes mellitus, %
|
83/16/1%
|
Dyslipidemia, %
|
67/20/13%
|
Smoking, (active smoker/quitted smoker), %
|
8/8%
|
Less than 1 pack per day
|
11%
|
1–2 packs per day
|
4%
|
More than 2 packs per day
|
1%
|
Serum lipid profile
|
Total cholesterol, mg/dL
|
190.4 ± 38.0
|
LDL cholesterol, mg/dL
|
112.1 ± 32.9
|
HDL cholesterol, mg/dL
|
52.2 ± 14.7
|
Triglyceride, mg/dL
|
122.0 ± 68.7
|
HbA1c
|
6.09 ± 0.88
|
Fasting plasma glucose
|
102.0 ± 24.0
|
Statin use (% in dyslipidemia)
|
77 (41%)
|
Current BMI, kg/m2
|
23.7 ± 4.3
|
Imaging biomarkers
|
Average Schelten’s score for MTA
|
1.62 ± 0.72
|
Average Fazekas score for WMH
|
0.90 ± 0.62
|
Entorhinal cortical thickness, mm
|
3.102 ± 0.429
|
Hippocampal volume, mm3
|
3283 ± 588.3
|